Tingfeng Yu - Publications

Author's reply: "Toward safer rechallenge after severe immune-mediated hepatotoxicity: The need for dynamic and mechanism-informed risk stratification".

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 04, 2026

Lipopolymer Nanoparticle-Mediated In Vivo CRISPR-Cas9 Editing of Mrg15 Restores Mitochondrial Mitophagy to Alleviate Metabolic-Associated Steatohepatitis.

Journal: Advanced healthcare materials

Published: April 08, 2026

DHRS9 knockdown attenuates severe acute pancreatitis by inhibiting ferroptosis through the modulation of redox homeostasis and oxylipin metabolism.

Journal: International immunopharmacology

Published: March 26, 2026

Risk factors and rechallenge outcomes in severe immune-mediated hepatotoxicity: Real-world evidence from two high-volume centers in China.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 19, 2025

Increased SLAMF7+CD8+ T cells are associated with the pathogenesis of experimental autoimmune pancreatitis in mice.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: April 17, 2023

Clinicopathological characteristics of IgG4-related lung disease.

Journal: BMC pulmonary medicine

Published: October 26, 2021

The function of IL-33/ST2 signaling axis in treg cells activating fibrosis in IgG4-related disease.

Journal: Human immunology

Published: June 27, 2021

The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis.

Journal: Arthritis research & therapy

Published: May 02, 2021